Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-074398)

Filing Details

Accession Number:: 0001104659-23-074398
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-23 20:00:34
Reporting Period:: 2023-06-22

Accepted Time:: 2023-06-23 20:00:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1871002	Chad Gassert	C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623	Svp - Corp. Dev. & Strategy	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-22	20,000	$51.32	373,226	No	4	S	Indirect	Held by Chali Properties LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Chali Properties LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	28,947	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.